Fig. 1From: Phase I/II clinical trial of efficacy and safety of EGCG oxygen nebulization inhalation in the treatment of COVID-19 pneumonia patients with cancerEnrollment and trial flow diagram. EGCG, epigallocatechin-3-gallate; MTD, maximum tolerated dose; NCI CTCAE, National Cancer Institute Common Terminology Criteria for Adverse EventsBack to article page